These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38659322)

  • 1. Blood serum levels of PACAP and migraine onset: A systematic review and meta-analysis of observational studies.
    Zhu G; Wang M; Kong F
    Headache; 2024 May; 64(5):573-588. PubMed ID: 38659322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
    Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
    Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
    Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
    Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
    Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
    Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
    Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
    Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
    Liu J; Wang G; Dan Y; Liu X
    J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
    Rustichelli C; Lo Castro F; Baraldi C; Ferrari A
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1269-1275. PubMed ID: 32877252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study.
    Storch E; Overeem LH; Terhart M; Fitzek MP; Lange KS; Reuter U; Raffaelli B
    J Headache Pain; 2024 Jun; 25(1):98. PubMed ID: 38858641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
    Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
    Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
    [No Abstract]   [Full Text] [Related]  

  • 11. Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.
    Amin FM; Schytz HW
    J Headache Pain; 2018 May; 19(1):35. PubMed ID: 29785578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
    Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
    Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention.
    Pellesi L; Ashina M; Martelletti P
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):57-64. PubMed ID: 38337150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage.
    Jiang L; Wang WH; Dong XQ; Yu WH; Du Q; Yang DB; Wang H; Shen YF
    Acta Neurol Scand; 2016 Aug; 134(2):131-9. PubMed ID: 26471292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.
    Sundrum T; Walker CS
    Br J Pharmacol; 2018 Nov; 175(21):4109-4120. PubMed ID: 28977676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.
    Tanaka M; Szabó Á; Körtési T; Szok D; Tajti J; Vécsei L
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Transcranial Direct Current Stimulation on Clinical Outcomes, Calcitonin Gene-Related Peptide, and Pituitary Adenylate Cyclase-Activating Polypeptide-38 Levels in Menstrual Migraine.
    Hasırcı Bayır BR; Aksu S; Gezegen H; Karaaslan Z; Yüceer H; Cerrahoğlu Şirin T; Küçükali Cİ; Kurt A; Karamürsel S; Yılmaz V; Baykan B
    Neuromodulation; 2024 Jul; 27(5):835-846. PubMed ID: 38506767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of PACAP in ischemia.
    Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
    J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
    Farajdokht F; Babri S; Karimi P; Alipour MR; Bughchechi R; Mohaddes G
    Eur J Neurosci; 2017 Mar; 45(6):763-772. PubMed ID: 27886414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).
    Okragly AJ; Morin SM; DeRosa D; Martin AP; Johnson KW; Johnson MP; Benschop RJ
    Cephalalgia; 2018 Aug; 38(9):1564-1574. PubMed ID: 29103295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.